Compare Cronos Group Inc (CRON) vs Phillips 66 (PSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Phillips 66 — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.11B), while Phillips 66 trades at $224.36 (market cap $86.00B). The key difference: Phillips 66 is far larger — about 77.5× Cronos Group Inc's market cap, and Phillips 66 pays a 2.36% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | PSX | |
|---|---|---|
Market Cap | $1.11B | $86.00B |
Sector | Health | Energy |
52-Week High | $3.27 | $224.36 |
52-Week Low | $2.30 | $120.04 |
Enterprise Value | $310.67M | $102.46B |
Dividend Yield | — | 2.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.
Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.
Phillips 66 (PSX) trades at $203.91, down 0.78% on the day, with a bearish technical signal but strong fundamental tailwinds from refining margins. Recent Q2 2026 earnings of $9.41 per share beat estimates, driven by high utilization and robust cash flow. The stock has support near $201 and resistance at $206, with a consensus price target of $221.92 suggesting upside potential.
Outlook is positive due to sustained refining profitability and debt reduction, but risks include volatile crude prices and geopolitical tensions. Analysts are predominantly bullish (57% buy ratings), though technical indicators warn of near-term pressure. Investors should weigh strong fundamentals against sector cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Phillips 66
Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →
